Alvaro Torres

Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC) announced its financial results on Monday for the quarter ended September 30, 2021 reporting revenues of CA$3.52 million ($2.78 million), compared to CA$1.93 million in the same period year ago. Q3 Financial Highlights...

A vertically integrated cannabis company Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC) announced Wednesday results from its first research study including 1,453 patients from Khiron-owned Zerenia Clinics. The results were officially presented at the 29th International...

Vertically integrated cannabis company Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) announced its latest financial results Monday, revealing a 68% year-over-year jump in revenue to CA$2.8 million (CA$2.18 million) in the second quarter of 2021. Shares traded up 1.96% at $ 0.2499 per share...

Khiron Appoints Dr. Eduardo Faveret As Medical Director For Zerenia Brazil Based in Toronto with operations in Latin America and Europe, vertically integrated cannabis company Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC) has named Dr. Eduardo Faveret, as medical...

Vertically integrated cannabis company Khiron Life Sciences Corp. (TSXV: KHRN)  (OTCQX: KHRNF) received a quota to export over 700 kg of high-THC extract to Mexico. Leveraging the Company's designation in Colombia as a National Strategic Project, Khiron Colombia SAS ...

As cannabis businesses in North America attempt to navigate the imminent recession, Colombia’s largest cannabis operators are sharing comments of tranquility in the midst of global market turmoil. Benzinga spoke with leaders at Colombia’s “Big 4” cannabis firms...

The first half of 2018 was a notably active period in the cannabis industry, particularly on the capital markets side. Over the first six months of the year, more than $4 billion in investments were made in the industry, according to Viridian Capital Advisors. Some of the most notable...

Canadian cannabis producer Tilray commenced trading on the Nasdaq this week, becoming the first pure-play marijuana company to list on a major U.S. stock exchange. “This week's listing of Tilray on NASDAQ is another positive move for cannabis stocks and particularly for the U.S....